Sort
23,748 grants matching “melanoma”
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system
$439,280Anna Karolina Palucka · Jackson Laboratory · R01 · FY2017 · CA
Novel Potent Autophagy Inhibitors for Melanoma
$439,280Jeffrey D Winkler · Wistar Institute · P01 · FY2014 · CA
Identification and development of inhibitors of the Hippo-Yap pathway
$439,200Joseph Kissil · Scripps Florida · R01 · FY2016 · CA
Identification and development of inhibitors of the Hippo-Yap pathway
$439,200Joseph Kissil · Scripps Florida · R01 · FY2015 · CA
Targeting TERT in Melanoma
$439,183Jessie Villanueva · Wistar Institute · R01 · FY2017 · CA
ERK control of Dendritic Cell Differentiation, Homeostasis and Disease
$439,083Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI
$439,061Thomas G Graeber · University Of California Los Angeles · P01 · FY2014 · CA
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$438,974Todd W Ridky · University Of Pennsylvania · R01 · FY2021 · CA
The Metabolic Regulation of Melanoma Metastasis
$438,803Sean J Morrison · Ut Southwestern Medical Center · U01 · FY2021 · CA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$438,800Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · CA
Mechanisms of liver metastasis and associated resistance to immunotherapy
$438,730Benjamin Izar · Columbia University Health Sciences · R37 · FY2022 · CA
Advancing T cell Therapy for Ovarian Cancer
$438,669George Coukos · Fox Chase Cancer Center · P50 · FY2009 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$438,609Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Dual-pronged nano-drug delivery using plant virus-like particles.
$438,466Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2018 · CA
Crosslinking conjugates to localize and activate NK cells in glioblastoma
$438,452Benjamin W. Purow · University Of Virginia · R21 · FY2019 · NS
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$438,385Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Developmental Funds
$438,343Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2012 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$438,296Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Clinical implementation of single cell tumor transcriptome analysis
$438,255Aviv Regev · Broad Institute, Inc. · R33 · FY2017 · CA
Clinical implementation of single cell tumor transcriptome analysis
$438,253Todd R. Golub · Broad Institute, Inc. · R33 · FY2018 · CA
Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy
$438,076Guillermo N Armaiz-Pena · Ponce School Of Medicine · R21 · FY2020 · CA
Apigenin restores TSP-1 expression in UVB-irradiated keratinocytes
$437,930Olga Valery Volpert · Northwestern University At Chicago · R01 · FY2014 · CA
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
$437,751Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Development of Virtual Tumor
$437,717Thomas S Deisboeck · Massachusetts General Hospital · U56 · FY2008 · CA
Development of Virtual Tumor
$437,717Thomas S Deisboeck · Massachusetts General Hospital · U56 · FY2007 · CA